Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis

Peritoneal metastasis (PM) is an advanced stage malignancy largely refractory to modern therapy. Intraperitoneal (IP) immunotherapy offers a novel approach for the control of regional disease of the peritoneal cavity by breaking immune tolerance. These strategies include heightening T-cell response...

Full description

Bibliographic Details
Main Authors: Anusha Thadi, Marian Khalili, William F. Morano, Scott D. Richard, Steven C. Katz, Wilbur B. Bowne
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Vaccines
Subjects:
intraperitoneal immunotherapy
vaccines
CAR-T cells
ascites
carcinoembryonic antigen
folate receptor α
dendritic cells
peritoneal
metastasis
Online Access:http://www.mdpi.com/2076-393X/6/3/54

Internet

http://www.mdpi.com/2076-393X/6/3/54

Similar Items